Healthcare & Pharmaceuticals

AstraZeneca confirms delays to COVID-19 shots produced in Latin America

1 minute read

A doctor prepares a dose of AstraZeneca's COVID-19 vaccine in his general practice, as the spread of the coronavirus disease (COVID-19) continues, in Vienna, Austria April 30, 2021. REUTERS/Leonhard Foeger

MEXICO CITY, April 30 (Reuters) - AstraZeneca (AZN.L) has confirmed setbacks to production of its COVID-19 vaccines in Latin America, excluding Brazil, but said it will still meet a commitment to deliver 150 million doses to the region this year.

The Anglo-Swedish drugmaker said in a statement shared with Reuters on Friday that lower-than-expected production, shortages of critical supplies and longer periods to meet internal controls had slowed the process.

Register now for FREE unlimited access to Reuters.com
Reporting by Adriana Barrera; Writing by Stefanie Eschenbacher; Editing by Frank Jack Daniel

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters